CANNABIS SUISSE CORP. Research and Development Expense
CANNABIS SUISSE CORP. (CSUI) reported Research and Development Expense of $0 for the 3-month period ending 2023-02-28, per its 10-Q filed 2023-04-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-04-19
- CANNABIS SUISSE CORP. research and development expense for the quarter ending 2023-02-28 was $0.00.
- CANNABIS SUISSE CORP. research and development expense for the quarter ending 2022-11-30 was $0.00, a 100.00% decline year-over-year.
- CANNABIS SUISSE CORP. research and development expense for the quarter ending 2022-02-28 was $0.00.
- CANNABIS SUISSE CORP. research and development expense for the quarter ending 2021-11-30 was $6.49K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month |
|---|---|---|---|
| 2023-02-28 | $0.00 10-Q · filed 2023-04-19 | $0.00 derived: sum of 2 quarters · filed 2023-04-19 | $0.00 10-Q · filed 2023-04-19 |
| 2022-11-30 | $0.00 10-Q · filed 2023-02-21 | $0.00 10-Q · filed 2023-02-21 | |
| 2022-02-28 | $0.00 10-Q · filed 2023-04-19 | $6.49K derived: sum of 2 quarters · filed 2023-04-19 | $6.49K 10-Q · filed 2023-04-19 |
| 2021-11-30 | $6.49K 10-Q · filed 2023-02-21 | $6.49K 10-Q · filed 2023-02-21 |